BackAvid Bioservices Overview

Avid Bioservices Income Tax

Track Avid Bioservices's income tax ($120M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Income Tax

$0
100.00% YoY

As of Oct 2024

Annual Income Tax (TTM)

$116.72M
84070.50% YoY

Trailing 12 months ending Oct 2024

Average Income Tax (Comparison Companies)

Loading

Income Tax History

Loading

Income Tax Comparison

Loading

Annual Income Tax Growth Rate (%)

Loading...

Annual Income Tax Growth (Absolute)

Loading...

Avid Bioservices (CDMO) FAQ

Avid Bioservices's income tax stands at $120M as of October 2024. That compares with $-140K in the prior-year period — up 84070.5% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Avid Bioservices reported $120M in income tax versus $-140K a year earlier — a 84070.5% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $-140K in the prior-year period — up 84070.5% year over year. Sustained growth in income tax can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Avid Bioservices's income tax evolved across reporting periods, while the comparison chart places CDMO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, income tax is commonly used to spot outliers. Avid Bioservices's reading of $120M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.